A new international study will examine the rare side effects caused by COVID-19 vaccines.
The University of Alberta in Canada is leading the study, through the विशेष टीकाकरण सेवाओं का अंतर्राष्ट्रीय नेटवर्क (INSIS). INSIS brings together specialist clinicians in vaccine safety, systems biology and genomics, including AusVaxSafety, to characterise the risk factors and underlying mechanism of adverse events following COVID-19 immunisation.
INSIS focuses on very rare adverse reactions, those which affect less than 0.001 % of the population, that occur after COVID-19 vaccination. This study aims to understand the causes and risk factors behind these occurrences, to ensure the development of even safer vaccines in potential future pandemics.
Read more on the Murdoch Children’s Research Institute (MCRI) website.
एमवीईसी: विशेष टीकाकरण सेवाओं का अंतर्राष्ट्रीय नेटवर्क
एमवीईसी: ऑसवैक्ससेफ्टी: ऑस्ट्रेलिया में वैक्सीन सुरक्षा निगरानी
MVEC: AEFI-CAN: Adverse Events Following Immunisation – Clinical Assessment Network